As of 4:02pm ET
| -0.01 / -0.02%|
The 21 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 64.00, with a high estimate of 75.00 and a low estimate of 49.00. The median estimate represents a +2.56% increase from the last price of 62.40.
The current consensus among 24 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.